Evidence map›Paper›PMID 30675438›Full record

ReviewKidney international supplements2018

Global overview of health systems oversight and financing for kidney care.

Aminu K Bello, Mona Alrukhaimi, Gloria E Ashuntantang, Ezequiel Bellorin-Font, Mohammed Benghanem Gharbi, Branko Braam, John Feehally, David C Harris, Vivekanand Jha, Kailash Jindal and 21 more

Abstract readReview
In one paragraph

Review in Kidney international supplements, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Paediatric nephrology in under-resourced areas.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Aminu K BelloDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Mona AlrukhaimiDepartment of Medicine, Dubai Medical College, Dubai, United Arab Emirates.
Gloria E AshuntantangFaculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde I, Yaounde, Cameroon.
Ezequiel Bellorin-FontDivision of Nephrology and Kidney Transplantation, Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela.
Mohammed Benghanem GharbiUrinary Tract Diseases Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca, Morocco.
Branko BraamDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
John FeehallyDepartment of Infection, Inflammation and Immunity, University Hospitals of Leicester, University of Leicester, Leicester, UK.
David C HarrisCentre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Vivekanand JhaGeorge Institute for Global Health India, New Delhi, India.
Kailash JindalDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
David W JohnsonCentre for Kidney Disease Research, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia.
Kamyar Kalantar-ZadehDivision of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California, USA.
Rumeyza KazanciogluDivision of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
Peter G KerrDepartment of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia.
Meaghan LunneyDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Timothy Olusegun OlanrewajuDepartment of Medicine, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Mohamed A OsmanDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Jeffrey PerlDivision of Nephrology, St. Michael's Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Harun Ur RashidDepartment of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Ahmed RatebDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Eric RondeauIntensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France.
Aminu Muhammad SakajikiDepartment of Medicine, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria.
Arian SamimiDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Laura SolaDivision Epidemiologia, Direccion General de Salud-Ministerio Salud Publica, Montevideo, Uruguay.
Irma TchokhonelidzeNephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia.
Natasha WiebeDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Chih-Wei YangKidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Feng YeDepartment of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Alexander ZemchenkovDepartment of Internal Disease and Nephrology, North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia.
Ming-Hui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Adeera LevinDepartment of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reliable governance and health financing are critical to the abilities of health systems in different countries to sustainably meet the health needs of their peoples, including those with kidney disease. A comprehensive understanding of existing systems and infrastructure is therefore necessary to globally identify gaps in kidney care and prioritize areas for improvement. This multinational, cross-sectional survey, conducted by the ISN as part of the Global Kidney Health Atlas, examined the oversight, financing, and perceived quality of infrastructure for kidney care across the world. Overall, 125 countries, comprising 93% of the world's population, responded to the entire survey, with 122 countries responding to questions pertaining to this domain. National oversight of kidney care was most common in high-income countries while individual hospital oversight was most common in low-income countries. Parts of Africa and the Middle East appeared to have no organized oversight system. The proportion of countries in which health care system coverage for people with kidney disease was publicly funded and free varied for AKI (56%), nondialysis chronic kidney disease (40%), dialysis (63%), and kidney transplantation (57%), but was much less common in lower income countries, particularly Africa and Southeast Asia, which relied more heavily on private funding with out-of-pocket expenses for patients. Early detection and management of kidney disease were least likely to be covered by funding models. The perceived quality of health infrastructure supporting AKI and chronic kidney disease care was rated poor to extremely poor in none of the high-income countries but was rated poor to extremely poor in over 40% of low-income countries, particularly Africa. This study demonstrated significant gaps in oversight, funding, and infrastructure supporting health services caring for patients with kidney disease, especially in low- and middle-income countries.

Indexed as

delivery of health caredeveloping countriesglobal health careglobal health governancehealth care financingnephrology

Identifiers

PMID30675438
PMCPMC6336220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.